Tanaka Y - Search Results

1

WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.

Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH. Kondo S, et al. Among authors: tanaka y. Oncogene. 1996 Sep 19;13(6):1279-85. Oncogene. 1996. PMID: 8808702

2

Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.

Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, Cowell JK. Kondo Y, et al. Among authors: tanaka y. Oncogene. 1998 Apr 30;16(17):2243-8. doi: 10.1038/sj.onc.1201754. Oncogene. 1998. PMID: 9619833

3

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation.

Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK, Barna BP. Kondo S, et al. Among authors: tanaka y. FASEB J. 1998 Jul;12(10):801-11. doi: 10.1096/fasebj.12.10.801. FASEB J. 1998. PMID: 9657520

4

Retroviral transfer of CPP32beta gene into malignant gliomas in vitro and in vivo.

Kondo S, Tanaka Y, Kondo Y, Ishizaka Y, Hitomi M, Haqqi T, Liu J, Barnett GH, Alnemri ES, Barna BP. Kondo S, et al. Among authors: tanaka y. Cancer Res. 1998 Mar 1;58(5):962-7. Cancer Res. 1998. PMID: 9500457

5

FADD gene therapy for malignant gliomas in vitro and in vivo.

Kondo S, Ishizaka Y, Okada T, Kondo Y, Hitomi M, Tanaka Y, Haqqi T, Barnett GH, Barna BP. Kondo S, et al. Among authors: tanaka y. Hum Gene Ther. 1998 Jul 20;9(11):1599-608. doi: 10.1089/hum.1998.9.11-1599. Hum Gene Ther. 1998. PMID: 9694158

6

Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.

Kondo Y, Tanaka Y, Shields JA, Kondo S. Kondo Y, et al. Among authors: tanaka y. Anticancer Res. 2001 Nov-Dec;21(6A):3765-72. Anticancer Res. 2001. PMID: 11911245

7

Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum.

Tanaka Y, Heminway BR, Galinski MS. Tanaka Y, et al. J Virol. 1996 Aug;70(8):5005-15. doi: 10.1128/JVI.70.8.5005-5015.1996. J Virol. 1996. PMID: 8764007 Free PMC article.

8

Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion.

Heminway BR, Yu Y, Tanaka Y, Perrine KG, Gustafson E, Bernstein JM, Galinski MS. Heminway BR, et al. Among authors: tanaka y. Virology. 1994 May 1;200(2):801-5. doi: 10.1006/viro.1994.1245. Virology. 1994. PMID: 8178462

9

Role of basic residues in the proteolytic activation of Sendai virus fusion glycoprotein.

Heminaway BR, Yang Y, Tanaka Y, Panin M, Huang YT, Galinski MS. Heminaway BR, et al. Among authors: tanaka y. Virus Res. 1995 Apr;36(1):15-35. doi: 10.1016/0168-1702(94)00102-i. Virus Res. 1995. PMID: 7625124

10

Human parainfluenza virus type 3: analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion.

Tanaka Y, Galinski MS. Tanaka Y, et al. Virus Res. 1995 May;36(2-3):131-49. doi: 10.1016/0168-1702(94)00111-o. Virus Res. 1995. PMID: 7653094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,327 results

Search Page

Filters